GlassScriptPhysician profile
Marta Taylor Becker
NPI 1467553081
$2,699.56
in general payments reported to CMS, 2019-2025
18 companies · $562 in 2025
The $562 reported for 2025 was more than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $34.78 · 2023: $482 · 2024: $1,622 · 2025: $562.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,138 · Travel and Lodging: $527.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,138.28 |
| Travel and Lodging | $526.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $648.71 | 2023-2024 | Fusion, Pteye Parathyroid Detection System, Propel |
| Regeneron Healthcare Solutions, INC. | $420.03 | 2023-2025 | Dupixent |
| Glaxosmithkline, LLC. | $396.59 | 2023-2025 | Nucala, Ojjaara, Blenrep |
| Genzyme Corporation | $357.55 | 2024-2025 | |
| Optinose US, INC. | $159.35 | 2024-2025 | |
| Integra Lifesciences Corporation | $109.89 | 2024 | Inspira Air, Acclarent Aera, Trudi Probe |
| Pfizer INC. | $100.33 | 2025 | |
| Phathom Pharmaceuticals, INC. | $98.37 | 2024-2025 | Voquezna |
| Stryker Corporation | $93.10 | 2023 | Xpress Ent Dilation System, Scopis Ent |
| Smith+Nephew, INC. | $72.78 | 2024 | Tula, Halo |
| Aerin Medical INC. | $71.47 | 2023-2025 | |
| Acclarent, INC | $65.77 | 2023 | Trudi Nav Cable |
| Bard Access Systems, INC. | $20.75 | 2019 | |
| Inspire Medical Systems, INC. | $18.95 | 2024 | Inspire |
| Merck Sharp & Dohme LLC | $18.15 | 2023 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $17.62 | 2025 | |
| Hikma Pharmaceuticals USA | $16.12 | 2025 | Ryaltris |
| Novartis Pharmaceuticals Corporation | $14.03 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marta Becker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.